| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 04/30/2009 | US20090111988 Novel process for production of 5--6-chloro-1,3-dihydro-2h-indol-2-one (ziprasidone) |
| 04/30/2009 | US20090111830 7-Chloro-2-[(4,4-difluorocyclohexyl)methyl]-1-oxoisoindoline-5-carbonitrile, used for the treatment of schizophrenia |
| 04/30/2009 | US20090111820 Fused pyrrolidine 1,2,4-triazole derivatives as modulators of mglur5 |
| 04/30/2009 | US20090110662 Modification of biological targeting groups for the treatment of cancer |
| 04/30/2009 | CA2704040A1 Synthesis of quaternary salt compounds |
| 04/30/2009 | CA2703717A1 Synthesis of quaternary salt compounds |
| 04/30/2009 | CA2703453A1 Indoline compounds |
| 04/30/2009 | CA2703157A1 Amino arylsulfonamide compounds and their use as 5-ht6 ligands |
| 04/30/2009 | CA2702798A1 5-lipoxygenase activating protein (flap) inhibitor |
| 04/29/2009 | EP2051962A1 (3-amino-1,2,3,4-tetrahydro-9h-carbazol-9-yl)-acetic acid derivatives |
| 04/29/2009 | EP2051961A1 Novel isoindol derivatives as ep4 receptor agonists |
| 04/29/2009 | EP2051707A2 Inhibitors of plasma kallikrein |
| 04/29/2009 | EP1765775B1 Indoles useful in the treatment of inflammation |
| 04/29/2009 | EP1558565B1 Halogenated selective androgen receptor modulators and methods of use thereof |
| 04/29/2009 | EP1511472B1 Compounds useful in the treatment of anthrax and inhibiting lethal factor |
| 04/29/2009 | EP1265640B1 Fluorescent membrane intercalating probes and methods for their use |
| 04/29/2009 | CN101421258A Sulfonyl-substituted bicyclic compounds as modulators of ppar |
| 04/29/2009 | CN101421239A Bicyclic tetrahydropyrrole compounds |
| 04/29/2009 | CN101421238A Method for producing polycyclic proline derivative or its acid addition salt |
| 04/29/2009 | CN101421237A Metabotropic glutamate receptor-potentiating soindolones |
| 04/29/2009 | CN101421236A Use of aryl- or alkyloxy-substituted phthalocyanines as marking substances for liquids |
| 04/29/2009 | CN101421235A 5-amido-2-carboxamide indoles |
| 04/29/2009 | CN101417972A 3-methylene-indol-2-one derivates and preparation method thereof |
| 04/29/2009 | CN101417971A Indolines compounds, preparation method and pharmaceutical application thereof |
| 04/29/2009 | CN100482667C Method for preparing 5-bromine-6-fluoro-8-methyl-1-ethyl-1,3,4,9- tetrahydropyrane[3,4-e] indole-1-ethyl acetate |
| 04/29/2009 | CN100482223C 5-halo-tryptamine derivatives used as ligands of 5-HT 6 and/or 5-HT7 serotonin receptors |
| 04/28/2009 | US7524883 Eponemycin and epoxomicin analogs and uses thereof |
| 04/28/2009 | US7524878 Phenyl substituted carboxylic acids |
| 04/28/2009 | US7524874 Vanilloid receptor ligands and their use in treatments |
| 04/28/2009 | US7524873 Substituted N-phenylmethyl ethanamines; N-((6-(methyloxy)-4'-(trifluoromethyl)-1,1'-biphenyl-3-yl)methyl)-1-(1-naphthalenyl)ethanamine; parathyroid hormone inhibitors; antisecretory agents; osteoporosis |
| 04/28/2009 | US7524863 Sulfonylaminovalerolactams and derivatives thereof as factor Xa inhibitors |
| 04/28/2009 | US7524846 heterocylcyclic amines used for treating or preventing conditions ameliorated by monoamine reuptake such as vasomotor symptoms, sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders |
| 04/28/2009 | US7524844 Dipeptidyl peptidase IV inhibitors, process for their preparation and compositions containing them |
| 04/28/2009 | US7524843 N-methyl-N-(1-methyl-1H-indol-3-ylmethyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide as an enzyme inhibitor for both Fab I and Fab K which are used in the biosynthesis of fatty acids; enoyl-acyl-carrier protein renamed Fab 1; bactericides; fungicides; Staphylococcus aureus; antibiotics |
| 04/28/2009 | US7524842 novel hydantoin derivatives to inhibit matrix metalloproteinases (MMPs), a disintegrin and metalloproteases (ADAMs) and/or tumor necrosis factor alpha converting enzyme (TACE) and in so doing prevent the release of tumor necrosis factor alpha (TNF- alpha ); autoimmune diseases; side effect reduction |
| 04/28/2009 | US7524839 Such as 1-phenylsulfonyl-4-piperazinylindole hydrochloride for treatment or prophylaxis of disease mediated by serotonin related receptor, obesity, and/or central nervous system disorder |
| 04/28/2009 | CA2486883C Method of manufacturing sertindole |
| 04/28/2009 | CA2425704C Tissue-specific exogenous optical agents |
| 04/28/2009 | CA2336783C Novel 2,3,3a,4,9,9a hexahydro-8-hydroxy-1h-benz[f]indoles, a method for the production thereof, and their use as medicaments |
| 04/28/2009 | CA2273328C 5-cyclo indole compounds as 5-ht1d receptor ligands |
| 04/28/2009 | CA2259922C Calcium receptor active compounds |
| 04/23/2009 | WO2009052350A1 Amine linked modulators of y-secretase |
| 04/23/2009 | WO2009051910A1 Compounds having activity in increasing ion transport by mutant-cftr and uses thereof |
| 04/23/2009 | WO2009051660A2 Compounds for activating tgf-beta signaling |
| 04/23/2009 | WO2009051417A2 Phenanthrene lactam derivatives having anticancer activity and method for the preparation thereof |
| 04/23/2009 | WO2009051000A1 Indolium compound and optical recording material using the compound |
| 04/23/2009 | WO2009050508A2 Separating liquids or liquid and solids and apparatus therefor |
| 04/23/2009 | WO2009050410A2 Carbene and co<sb>2</sb> adducts and use thereof for co<sb>2</sb> extraction |
| 04/23/2009 | WO2009050041A1 Novel carbamoylglycine derivatives |
| 04/23/2009 | WO2009032558A3 Preparation of ziprasidone hydrochloride monohydrate |
| 04/23/2009 | WO2008152094A3 Substituted acetamides as modulators of the ep2 receptor |
| 04/23/2009 | US20090105489 Novel organic compound and method for producing radioactive halogen-labeled organic compound using the same |
| 04/23/2009 | US20090105487 Conjugated compounds containing heteroatom-center-arylsilane derivatives and their application |
| 04/23/2009 | US20090105474 Novel anthranilic acid derivative or salt thereof |
| 04/23/2009 | US20090105327 Dibenzocycloheptane compounds and pharmaceuticals containing these compounds |
| 04/23/2009 | US20090105321 useful for the treatment of EP4 mediated diseases or conditions, such as acute and chronic pain, osteoarthritis, rheumatoid arthritis, cancer and glaucoma; 4-[(1S)-1-({[1-(3-chlorobenzyl)-2,3-dihydro-1H-indol-7-yl]carbonyl}amino)ethyl]benzoic acid |
| 04/23/2009 | US20090105256 Prodrugs of ion channel modulating compounds and uses thereof |
| 04/23/2009 | US20090105241 Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives |
| 04/23/2009 | US20090105223 Compound Having Activity Of Blocking NMDA Receptor Channel, and Pharmaceutical Agent Using The Same |
| 04/23/2009 | US20090105216 3- (aminomethyliden) 2-indolinone derivates and their use as cell proliferation inhibitors |
| 04/23/2009 | US20090105091 Modified Amino Acids |
| 04/23/2009 | US20090102360 Anthracene derivative, material for light emitting element, light emitting element, light emitting device, and electronic appliance |
| 04/23/2009 | CA2703636A1 Amine linked modulators of .gamma.-secretase |
| 04/22/2009 | EP2050744A1 Quinazoline derivatives as angiogenesis inhibitors |
| 04/22/2009 | EP2050450A1 1-Piperidine-2-cyanoimino-1,3-dihydro-2H-benzimidazole derivatives as nociceptin analogs with ORL1 modulating activity for the treatment of pain |
| 04/22/2009 | EP2049520A2 Indole compounds |
| 04/22/2009 | EP2049485A1 Naphthalene derivatives used as ep4 receptor agonists |
| 04/22/2009 | EP2049484A1 Isoindoline derivatives for the treatment of arrhythmias |
| 04/22/2009 | EP2049482A1 Positively charged water-soluble prodrugs of aryl- and heteroarylacetic acids with very fast skin penetration rate |
| 04/22/2009 | EP2049481A2 Novel compounds as antagonists or inverse agonists for opioid receptors |
| 04/22/2009 | EP2049480A1 2-arylindole derivatives as npges-i inhibitors |
| 04/22/2009 | EP1802572B1 Indol derivatives as inhibitors of soluble adenylyl cyclase |
| 04/22/2009 | EP1692229B1 Polymeric dispersant |
| 04/22/2009 | EP1558575B1 Process for preparation of carvedilol |
| 04/22/2009 | EP1381366B1 Indole, azaindole and related heterocyclic amidopiperazine derivatives |
| 04/22/2009 | CN101415680A Benzoisoindole derivatives for the treatment of pain |
| 04/22/2009 | CN101415679A Water-solubility CC-1065 analog and composition thereof |
| 04/22/2009 | CN101415678A Benzo[F]isoindol-2-ylphenyl acetic acid derivatives as EP4 receptor agonists |
| 04/22/2009 | CN101415677A Method for producing polycyclic lactam compounds |
| 04/22/2009 | CN101415676A N-tert-butoxycarbonyl-2-pyrrolidinone compounds and method for producing the same |
| 04/22/2009 | CN101412691A Carbazolyl bis(alpha, beta)-unsaturated ketones and preparation thereof |
| 04/22/2009 | CN101412690A Medicinal acid addition salt of silodosin, and preparation and medicament use thereof |
| 04/22/2009 | CN101412682A Process for synthesizing aryl anthranilic acid and derivatives thereof |
| 04/22/2009 | CN100481571C Luminescent element material and luminescent element comprising the same |
| 04/22/2009 | CN100480248C Malonamide derivatives as gamma-secretase inhibitors |
| 04/22/2009 | CN100480240C Prepn process of Ropinirole and derivative thereof |
| 04/21/2009 | US7521566 N-[(S)-1-carbethoxybutyl]-(S)-alanine carboxylic acid halide is reacted with benzyl ester of (2S, 3aS, 7aS)-2-carboxyperhydroindole, followed by catalytic hydrogenation to give perindopril |
| 04/21/2009 | US7521480 Such as 2-[3-(3-Bromo-phenyl)-ureido]-4-chloro-5-methyl-benzenesulfonic acid which is selective and non-competitive antagonist of ionotropic GluR5 receptor |
| 04/21/2009 | US7521472 Crystal of two-ring heterocyclic sulfonamide compound |
| 04/21/2009 | US7521451 e.g. 5,6-dimethyl-3a,4,7,7a-tetrahydro-2-benzofuran-1,3-dione;intravenous, water-soluble compounds useful for manufacturing an anasthetic, sedative agents; side effect reduction |
| 04/21/2009 | US7521445 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands |
| 04/21/2009 | US7521062 Thiosemicarbazones as anti-virals and immunopotentiators |
| 04/21/2009 | CA2362003C Heterocyclic urea and related compounds useful as anti-inflammatory agents |
| 04/21/2009 | CA2182949C Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis |
| 04/16/2009 | WO2009048953A1 Thrombopoietin receptor agonist (tpora) kills acute human myeloid leukemia cells |
| 04/16/2009 | WO2009047797A2 Process for the preparation of perhydroisoindole derivative |
| 04/16/2009 | WO2009047240A1 Indole derivatives useful as ppar activators |
| 04/16/2009 | WO2009046841A2 Piperidine and piperazine derivatives for treating tumours |
| 04/16/2009 | WO2009046665A1 Isoindole compounds and their uses |
| 04/16/2009 | WO2009020234A3 Pyrrolidin-2 -one derivatives as androgen receptor modulator |